Auricular Neoplasia and Pinnectomy

Auricular neoplasia refers to benign or malignant tumors arising from the skin, adnexa, cartilage, or soft tissues of the pinna (auricle). Pinnectomy is the surgical excision of part or all of the pinna, performed as a therapeutic or curative procedure for auricular neoplasms, severe trauma, or chronic inflammatory conditions. The pinna is a cartilaginous framework covered by skin, with a rich vascular supply and innervation. Tumors may be localized to the pinna or extend into the external ear canal, middle ear, or regional lymph nodes. Surgical management requires a thorough understanding of auricular anatomy, tumor biology, and reconstructive techniques to achieve complete excision with acceptable cosmetic and functional outcomes.

The etiology of auricular neoplasia is multifactorial. Chronic solar exposure is a well-documented cause of squamous cell carcinoma (SCC) in cats, particularly in white or lightly pigmented individuals. Papillomavirus infection has been implicated in the development of squamous papillomas and some SCCs. Chronic inflammation, such as that seen in chronic otitis externa, may predispose to the development of ceruminous gland adenomas or adenocarcinomas. Genetic factors, including breed predispositions, play a role in certain tumor types, such as mast cell tumors in Boxers and ceruminous gland tumors in Cocker Spaniels. Immunosuppression, either iatrogenic or due to concurrent disease, may increase the risk of cutaneous neoplasia. Trauma and chronic irritation have been suggested as contributing factors, though evidence is limited. For benign tumors, such as papillomas and fibromas, the etiology is often unknown but may involve viral or genetic factors.

Auricular neoplasia is relatively uncommon in dogs and cats, accounting for a small percentage of all skin tumors. In cats, squamous cell carcinoma is the most common auricular tumor, with a higher incidence in white, outdoor cats with non-pigmented skin. The mean age of affected cats is 10-12 years. In dogs, mast cell tumors, histiocytomas, and ceruminous gland tumors are more frequently seen. Certain breeds, such as Cocker Spaniels, Poodles, and Labrador Retrievers, may have a higher incidence of ceruminous gland tumors. Mast cell tumors are more common in brachycephalic breeds, including Boxers, Boston Terriers, and Bulldogs. There is no significant sex predilection for most auricular tumors. The prevalence of auricular neoplasia is higher in older animals, reflecting the general increase in cancer risk with age.

The pathophysiology of auricular neoplasia varies with tumor type. Squamous cell carcinoma arises from keratinocytes in the epidermis, often in areas of chronic sun damage. UV radiation induces DNA mutations, leading to uncontrolled keratinocyte proliferation. Tumors may be locally invasive, with a tendency to metastasize to regional lymph nodes (parotid, mandibular) and, less commonly, to distant sites. Mast cell tumors originate from mast cells in the dermis and can release vasoactive substances (histamine, heparin) causing local inflammation and pruritus. They are graded based on histologic features (Patnaik or Kiupel grading) and can be locally aggressive with variable metastatic potential. Ceruminous gland tumors arise from apocrine glands in the external ear canal and can be benign (adenoma) or malignant (adenocarcinoma). Malignant forms are locally invasive and may metastasize to regional lymph nodes and lungs. Other tumors, such as fibrosarcomas, hemangiosarcomas, and melanomas, are less common but exhibit aggressive local behavior and metastatic potential. The pinna's rich vascular supply facilitates hematogenous spread of malignant tumors. Tumor growth can cause pain, ulceration, secondary infection, and cosmetic disfigurement.

Predisposing factors for auricular neoplasia include: (1) Chronic solar exposure, especially in cats with white or non-pigmented pinnae; (2) Chronic otitis externa or media, leading to chronic inflammation and metaplasia of ceruminous glands; (3) Breed predispositions, such as Boxers for mast cell tumors and Cocker Spaniels for ceruminous gland tumors; (4) Age, with older animals at higher risk; (5) Immunosuppression, either from disease (e.g., FIV, FeLV) or drug therapy; (6) Viral infections, particularly papillomavirus; (7) Genetic mutations, such as mutations in the c-kit gene in mast cell tumors; (8) Environmental carcinogens, though less well-defined; (9) Prior radiation exposure; (10) Chronic trauma or irritation, though evidence is anecdotal.

Clinical signs of auricular neoplasia depend on tumor type, size, and location. Common findings include: (1) A visible or palpable mass on the pinna, which may be nodular, ulcerated, or alopecic; (2) Pruritus or pain, leading to head shaking or scratching; (3) Otic discharge, if the tumor involves the ear canal; (4) Foul odor, due to secondary bacterial or yeast infection; (5) Bleeding or crusting from the tumor surface; (6) Aural hematoma, if trauma occurs; (7) Facial nerve paralysis, if the tumor invades the middle ear or parotid region; (8) Enlargement of regional lymph nodes (parotid, mandibular) in cases of metastasis; (9) Systemic signs, such as lethargy, anorexia, and weight loss, in advanced disease. On physical examination, the tumor may be sessile or pedunculated, with variable consistency. Ulcerated tumors may be painful and prone to bleeding. In cats with solar-induced SCC, lesions often appear as erythematous, crusty, or ulcerated plaques on the ear tips.

Differential diagnoses for auricular neoplasia include: (1) Aural hematoma: A fluctuant swelling of the pinna due to trauma or otitis, typically not neoplastic; (2) Chronic otitis externa: Inflammation of the ear canal, which may cause swelling and discharge, but not a discrete mass; (3) Ear margin dermatosis: A condition characterized by crusting and alopecia of the ear margins, often due to vasculitis or autoimmune disease; (4) Cutaneous cysts: Epidermoid or dermoid cysts may present as nodules; (5) Foreign body reaction: A granuloma caused by a foreign body, such as a grass awn; (6) Abscess: A localized infection, often painful and fluctuant; (7) Autoimmune diseases, such as pemphigus foliaceus, which can cause crusting and ulceration of the pinna; (8) Parasitic infections, such as demodicosis or sarcoptic mange, which can cause alopecia and crusting; (9) Other cutaneous neoplasms, such as fibrosarcoma, hemangiosarcoma, or melanoma, which require histopathology for differentiation; (10) Inflammatory polyps, which are more common in the ear canal but can extend to the pinna.

The diagnostic algorithm for auricular neoplasia begins with a thorough history and physical examination, including otoscopic examination of the ear canal. Fine-needle aspiration (FNA) of the mass is often the first step, allowing cytologic evaluation. For mast cell tumors, cytology may reveal characteristic granules. For SCC, cytology may show keratinocytes with dysplastic features. If FNA is inconclusive, a biopsy (incisional or excisional) is indicated. Imaging, such as radiography or CT, may be performed to assess the extent of the tumor, especially if there is suspicion of middle ear involvement or metastasis. Thoracic radiographs are recommended to screen for pulmonary metastasis. Regional lymph node aspiration or biopsy is performed to assess for metastasis. Advanced imaging, such as MRI, may be useful for evaluating soft tissue extension. Staging of the tumor, based on histologic grade and clinical stage, guides treatment decisions. Surgical planning involves determining the extent of pinnectomy required to achieve clean margins, which may be confirmed by histopathologic evaluation of surgical margins.

Laboratory findings in auricular neoplasia are often non-specific. Complete blood count (CBC) may reveal anemia of chronic disease or leukocytosis due to secondary infection. Serum biochemistry may show hyperglobulinemia or elevated liver enzymes if metastatic disease is present. In mast cell tumors, a buffy coat smear may be evaluated for circulating mast cells, though this is not a reliable indicator of metastasis. Coagulation panel (PT/aPTT) is recommended if surgery is planned, especially if the tumor is large or vascular. Urinalysis is performed as part of a minimum database. In cats, testing for FeLV and FIV is recommended, as these viruses may influence prognosis. Inflammatory biomarkers, such as C-reactive protein (CRP) or serum amyloid A (SAA), may be elevated in cases of inflammation or malignancy, but are not specific. Cytologic evaluation of fine-needle aspirates is a key laboratory finding, as it can provide a preliminary diagnosis. Histopathology is the gold standard for definitive diagnosis and grading.

Imaging plays a crucial role in the evaluation of auricular neoplasia. Radiography of the skull may reveal soft tissue swelling or mineralization within the tumor, but is of limited value for soft tissue detail. Thoracic radiographs are essential for staging, as they can detect pulmonary metastases. Computed tomography (CT) provides excellent detail of the pinna, ear canal, and surrounding structures, and is particularly useful for assessing the extent of tumors involving the ear canal or middle ear. CT can also be used to evaluate regional lymph nodes. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and is valuable for assessing invasion into the middle ear, tympanic bulla, or brain. Ultrasonography may be used to evaluate regional lymph nodes for metastasis, and can guide fine-needle aspiration. In cases of suspected vascular invasion, angiography or fluoroscopy may be performed, though this is uncommon. Advanced imaging is particularly important for surgical planning, as it allows the surgeon to determine the extent of resection needed and to identify any involvement of vital structures.

Cytology and histopathology are essential for the diagnosis and grading of auricular neoplasia. Fine-needle aspiration (FNA) of the mass can provide a rapid preliminary diagnosis. For mast cell tumors, cytology typically reveals a population of round cells with intracytoplasmic granules. For squamous cell carcinoma, cytology may show keratinocytes with nuclear atypia and keratin pearls. Ceruminous gland tumors may show clusters of epithelial cells with variable atypia. Histopathology is required for definitive diagnosis and grading. For mast cell tumors, the Patnaik grading system (I, II, III) or the Kiupel two-tier system (low vs. high grade) is used to predict biologic behavior. For squamous cell carcinoma, histologic features such as degree of differentiation, depth of invasion, and perineural or lymphatic invasion are noted. Ceruminous gland adenomas are well-differentiated, while adenocarcinomas show cellular atypia, invasion, and mitotic activity. Surgical margins are evaluated for completeness of excision. Special stains, such as immunohistochemistry for c-kit (CD117) in mast cell tumors, may be performed to guide targeted therapy. Histopathology also helps differentiate between benign and malignant lesions, which is critical for determining prognosis and the need for adjuvant therapy.

The primary treatment for auricular neoplasia is surgical excision, with pinnectomy being the most common procedure. The extent of pinnectomy depends on the size and location of the tumor. For small tumors, a wedge resection or partial pinnectomy may be sufficient. For larger or more invasive tumors, total pinnectomy may be required. The surgical approach involves careful dissection of the skin and cartilage, with attention to preserving the vascular supply. The auricular cartilage is incised, and the skin is closed in layers. Suture materials such as polydioxanone (PDS) or polypropylene are used for cartilage, and nylon or polypropylene for skin. In cases of extensive resection, reconstructive techniques such as skin flaps or grafts may be necessary. For tumors involving the ear canal, a lateral ear canal resection or total ear canal ablation (TECA) may be combined with pinnectomy. Regional lymph node extirpation is performed if metastasis is suspected. Adjuvant therapy, such as radiation therapy or chemotherapy, may be recommended for high-grade or metastatic tumors. For mast cell tumors, tyrosine kinase inhibitors (e.g., toceranib) may be used. For squamous cell carcinoma, photodynamic therapy or cryotherapy may be options for superficial lesions. Postoperative pain management includes opioids (e.g., buprenorphine 0.01-0.02 mg/kg IV or IM q8-12h) and non-steroidal anti-inflammatory drugs (e.g., carprofen 2.2 mg/kg PO q12h). Antibiotics (e.g., cefazolin 22 mg/kg IV at induction) are administered perioperatively.

The prognosis for auricular neoplasia depends on tumor type, grade, stage, and completeness of excision. Benign tumors, such as papillomas and ceruminous adenomas, have an excellent prognosis after complete surgical excision. Low-grade mast cell tumors (Patnaik grade I or Kiupel low grade) have a good prognosis, with a median survival time of over 2 years. High-grade mast cell tumors (grade III or high grade) have a poorer prognosis, with a median survival time of less than 6 months. Squamous cell carcinoma in cats has a guarded prognosis, especially if there is deep invasion or metastasis; however, early-stage lesions treated with surgery or radiation may have a good outcome. Ceruminous gland adenocarcinomas have a moderate prognosis, with a median survival time of 1-2 years, depending on stage. Negative prognostic indicators include incomplete surgical margins, high histologic grade, lymph node metastasis, and distant metastasis. Postoperative complications, such as wound dehiscence or infection, can affect outcome but are usually manageable. Overall, early detection and complete surgical excision offer the best chance for long-term control.

Postoperative follow-up for pinnectomy includes: (1) Suture removal in 10-14 days; (2) Serial physical examinations every 1-3 months for the first year, then every 6 months thereafter, to monitor for local recurrence or metastasis; (3) Thoracic radiographs every 3-6 months for the first year, then annually, for tumors with metastatic potential; (4) Regional lymph node palpation and aspiration if enlargement is detected; (5) Histopathologic evaluation of surgical margins to confirm complete excision; (6) If radiation therapy is administered, regular dermatologic assessments for radiation side effects; (7) If chemotherapy is used, monitoring of blood counts and biochemistry to assess toxicity; (8) Owner education on wound care, including keeping the surgical site clean and preventing self-trauma (e.g., using an Elizabethan collar); (9) Gradual return to normal activity, with restricted exercise for 2-4 weeks postoperatively; (10) Long-term monitoring for any new skin lesions, especially in cats with solar-induced SCC, as they are at risk for developing additional tumors.

Clinical pearls: (1) Always perform a thorough otoscopic examination to assess the ear canal for concurrent disease; (2) Use a surgical marker to outline the planned excision margins, ensuring at least 1-2 cm of normal tissue for malignant tumors; (3) For mast cell tumors, administer antihistamines (e.g., diphenhydramine 2 mg/kg PO q8h) and H2 blockers (e.g., famotidine 0.5 mg/kg PO q12h) preoperatively to reduce the risk of histamine release; (4) When performing a total pinnectomy, preserve as much skin as possible for closure, and consider a cosmetic reconstruction using a skin flap; (5) Use a head bandage to protect the surgical site and minimize hematoma formation; (6) For cats with solar-induced SCC, recommend sun protection (e.g., sunscreen or limiting outdoor exposure) to prevent new lesions; (7) Submit all excised tissue for histopathology, even if the tumor appears benign; (8) Consider sentinel lymph node mapping for high-grade tumors to guide lymph node extirpation; (9) Use a bipolar electrocautery for hemostasis to minimize thermal damage to surrounding tissue; (10) For tumors involving the ear canal, plan for a TECA if the canal is occluded or severely diseased. Pitfalls: (1) Incomplete excision due to inadequate margins, leading to recurrence; (2) Damage to the facial nerve during surgery, especially if the tumor is near the base of the ear; (3) Failure to assess regional lymph nodes, missing metastasis; (4) Postoperative hematoma or seroma formation due to inadequate hemostasis or dead space; (5) Wound dehiscence due to excessive tension on the skin closure; (6) Underestimating the aggressiveness of a tumor based on cytology alone, leading to inadequate surgical planning; (7) Neglecting to perform thoracic radiographs, missing pulmonary metastasis; (8) Using absorbable sutures on the skin, which can cause irritation and increase the risk of infection; (9) Not providing adequate postoperative pain management, leading to self-trauma; (10) Failing to consider adjuvant therapy for high-grade tumors, resulting in a poorer outcome.

Perioperative drug protocols for pinnectomy are based on Plumb's Veterinary Drug Handbook. Prophylactic antimicrobials: Cefazolin (22 mg/kg IV) administered at induction and repeated every 90 minutes during surgery. Postoperative antibiotics are not routinely indicated unless infection is present or a large resection is performed. Analgesics: Opioids such as buprenorphine (0.01-0.02 mg/kg IV or IM q8-12h) or hydromorphone (0.05-0.1 mg/kg IV or IM q4-6h) are used for moderate to severe pain. Non-steroidal anti-inflammatory drugs (NSAIDs) such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) are administered postoperatively for 3-5 days, provided there are no contraindications. Local anesthesia: A ring block with bupivacaine (1-2 mg/kg, maximum 2 mg/kg) or lidocaine (2 mg/kg) can be performed at the base of the ear to provide intraoperative and postoperative analgesia. For mast cell tumors, premedication with diphenhydramine (2 mg/kg PO or IM) and famotidine (0.5 mg/kg IV or PO) is recommended to block histamine receptors. If chemotherapy is indicated, protocols may include vinblastine (2 mg/m² IV every 2 weeks) for mast cell tumors, or carboplatin (300 mg/m² IV every 3 weeks) for squamous cell carcinoma. Tyrosine kinase inhibitors such as toceranib (2.75 mg/kg PO every other day) are used for mast cell tumors with c-kit mutations. For cats with SCC, piroxicam (0.3 mg/kg PO q48h) may be used as adjunctive therapy. All dosages should be adjusted based on renal and hepatic function, and patients should be monitored for adverse effects.

The surgical management of auricular neoplasia is well-documented in veterinary literature. Fossum's Small Animal Surgery provides comprehensive guidelines on pinnectomy techniques, emphasizing the importance of complete excision and cosmetic reconstruction. Tobias & Johnston's Veterinary Surgery: Small Animal discusses the biology and surgical treatment of auricular tumors, including mast cell tumors and squamous cell carcinoma. Studies have shown that complete surgical excision of low-grade mast cell tumors results in a median survival time of over 2 years, while high-grade tumors have a poorer prognosis. A retrospective study by London et al. (1999) reported that dogs with grade II mast cell tumors treated with surgery alone had a 1-year survival rate of 94%. For squamous cell carcinoma in cats, a study by Lana et al. (1997) found that surgical excision or radiation therapy resulted in a median progression-free interval of 19 months. The use of toceranib for mast cell tumors has been supported by a prospective study by London et al. (2009), which showed a 42% overall response rate. Sentinel lymph node mapping has been investigated as a means to improve staging and guide lymph node extirpation, with promising results. Consensus guidelines from the ACVS and ECVS recommend histopathologic evaluation of surgical margins and staging of tumors to guide adjuvant therapy. Overall, the evidence supports aggressive surgical resection with clean margins as the cornerstone of treatment for auricular neoplasia, with adjuvant therapy reserved for high-grade or metastatic disease.